mogamulizumab
AssetAlso Poteligeo, AMG-761, KM-8761, KW-0761
Binds CCR4 on malignant T cells and induces antibody-dependent cellular cytotoxicity.
- Stage
- Stage not known
- Modality
- Antibody
- Target
- CCR4
- 0
- Indications
- 0
- Trials
- 1
- Developer
Indications
0In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.